Shexiang Baoxin Pills for Coronary Heart Disease in Animal Models: Preclinical Evidence and Promoting Angiogenesis Mechanism

• Egile Nagusiak: Ke-Jian Zhang (Egilea), Jia-Zhen Zhu (Egilea), Xiao-Yi Bao (Egilea), Qun Zheng (Egilea), Guo-qing Zheng (Egilea), Yan Wang (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2017-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Shexiang Baoxin Pill (SBP) originated from a classical TCM Fufang Suhexiang Pill for chest pain with dyspnea in the Southern Song Dynasty (1107-110 AD). Here, we aimed to evaluate preclinical evidence and possible mechanism of SBP for experimental coronary heart disease (CHD). Studies of SBP in anim...